HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juvenile arthritis and uveitis.

Abstract
The association between juvenile arthritis and uveitis is reviewed. Some children with the HLA-B27 related spondyloarthropathies develop anterior uveitis. About 20% of patients with juvenile rheumatoid arthritis (JRA) who are negative for IgM rheumatoid factor develop a frequently bilateral, nongranulomatous chronic anterior uveitis. Risk factors for uveitis in JRA patients are: female gender, pauciarticular onset of arthritis, presence of circulating antinuclear antibodies, and the antigens HLA-DW5 and HLA-DPw2. Uveitis is rare after seven years or more have elapsed from the onset of arthritis. The visual prognosis in patients with uveitis is good in 25% and fair in 50%. The remaining 25% develop visual impairment from complicated cataract and/or secondary inflammatory glaucoma. The potential benefit of cytotoxic agents in the treatment of intractable uveitis is outweighed by the risk of serious side effects. The management of secondary inflammatory glaucoma is unsatisfactory, but the results of treatment of complicated cataracts by lensectomy-vitrectomy are good.
AuthorsJ J Kanski
JournalSurvey of ophthalmology (Surv Ophthalmol) 1990 Jan-Feb Vol. 34 Issue 4 Pg. 253-67 ISSN: 0039-6257 [Print] United States
PMID2188388 (Publication Type: Journal Article, Review)
Topics
  • Adolescent
  • Arthritis, Juvenile (complications, diagnosis, drug therapy, epidemiology)
  • Child
  • Child, Preschool
  • Female
  • Glaucoma (etiology)
  • Humans
  • Infant
  • Male
  • Risk Factors
  • Uveitis, Anterior (complications, diagnosis, drug therapy, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: